Two-Year Outcomes After Implantation Of Xience Prime And Xience Prime Long Lesion Stents In Patients With Coronary Artery Disease: Results Of The Spirit Prime Multicenter Pivotal Clinical Trial

Marco Costa,Dean Kereiakes,Robert Smith, Ken Wu,Xiaohe Yu,Louis Cannon,John Wang,Krishnankutty Sudhir

Journal of the American College of Cardiology（2012）

引用 6|浏览7

暂无评分

摘要

The SPIRIT PRIME trial demonstrated the clinical equivalence of the next generation XIENCE PRIME everolimus-eluting stent (EES, Abbott Vascular, Santa Clara, CA) to the XIENCE V EES at 1 year. Longer-term outcomes with the XIENCE PRIME stent have not been investigated. SPIRIT PRIME, a prospective,

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要